AZORG HOSPITALS Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform

AZORG HOSPITALS Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform

AZORG HOSPITALS Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform

AZORG HOSPITALS Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform

Powerful Medical Powerful Medical
Powerful Medical wordmark logo in white

Leading the AI revolution in cardiovascular care

The mission behind pmcardio

Powerful Medical is redefining the landscape of medical diagnostics with its AI-driven solutions. The company’s certified PMcardio platform revolutionizes the way cardiovascular diseases are detected, offering rapid and accurate diagnostics that pave the way for timely and effective treatment.

Our impact in numbers

120kHeart Attacks Detected

  • 100,000+Clinicians Worldwide
  • 2.5M+ECGs Analyzed
  • 25+Clinical Validation Studies
  • 150+Hospital Deployments

70+ clinicians have personally invested in Powerful Medical

Emergency physicians and cardiologists across the US and Europe have put more than $5M of their own money behind Powerful Medical — the same professionals who rely on PMcardio to make the right call for their patients every day.

Powerful Medical team collage of photos from cardiology conferences, award ceremonies, and events

Awards & Recognition

  • 2026
  • JACC
  • Cardiovascular Interventions — Spencer King Award 2025: Awarded for the TCT Late-Breaker paper
  • 2025
  • MedTech Innovator
  • Grand Prize Winner: $200,000 Grand Prize awarded from the world's largest medtech accelerator
  • 2025
  • Deloitte
  • Deloitte Fast 50 Winner: Impact Category for Healthcare
  • 2025
  • FDA
  • FDA Breakthrough Device Designation and TAP Program: PMcardio STEMI AI ECG Model (Queen of Hearts™).
  • 2025
  • European Heart Journal
  • Most cited and viewed paper in European Heart Journal – Digital Health, the landmark validation study of Queen of Hearts™
  • 2024
  • AHA
  • AHA Health Tech Competition 2024 — Best Science Pitch and Overall Winner: First company ever to win both at the 100th AHA Scientific Sessions.
  • 2024
  • Forbes
  • Forbes 30 Under 30 Europe: Co-founders Martin Herman and Dr. Robert Herman.
  • 2024
  • Google
  • Google for Startups Growth Academy — AI for Health: Selected from 500+ EMEA applicants.
  • 2023
  • European Union
  • European Parliament SME Award 2023
  • 2023
  • CVCA
  • Venture Capital Deal of the Year Award - CVCA
  • 2023
  • Ministry of Education in Slovakia
  • Scientific and Technical Team of the Year

+ 45 other awards and Recognitions

Significant Milestones

2026 Year to Date

  • AI ECG TIMI Study completes patient enrolment — 703 patients across 9 sites in Belgium, Italy, and Austria.

  • Approximately 75% of acute MI patients in Slovakia now benefit from PMcardio.

2025 From Clinical Validation to FDA-Class Evidence

  • FDA Breakthrough Device Designation granted for the Queen of Hearts™ STEMI AI ECG Model.

  • €40M non-dilutive IPCEI Tech4Cure grant awarded by the European Commission — among the largest EU healthcare-tech contributions to date.

  • PMcardio 3.0 launched. Full health-system deployments, LVsense™ (reduced EF) Module and new user interface

  • Late-Breaking Clinical Science at TCT 2025, San Francisco. Presented by Dr. Timothy D. Henry: Queen of Hearts™ reduced false-positive cath-lab activations five-fold and significantly improved STEMI detection.

  • DIFOCCULT-3 RCT results presented at TCT 2025 — the largest RCT of AI in cardiology (6,000 ACS patients); approximately 5-hour reduction in ECG-to-balloon time.

2024 Unprecedented Growth

  • Registered clinicians nearly doubled to 60,000 (from 32,000).

  • €2.5M grant from the European Innovation Council for Queen of Hearts™ validation

  • MDSAP, SOC 2 Type II, ISO 27001 certification, and HIPAA compliance achieved.

  • PMcardio for Organizations launched — an enterprise platform with desktop, web, and notification capabilities designed for health systems.

2023 Commercial Launch and First Clinical Validation

  • PMcardio officially launched — the first CE-certified AI platform for ECG interpretation.

  • Queen of Hearts™ STEMI AI ECG Model released. Detects heart attacks on average 3 hours faster and with twice the sensitivity of standard STEMI criteria.

  • First independent validation studies in Cardiovascular Digital Health Journal, European Heart Journal — Digital Health, and Journal of Electrocardiology.

  • PMcardio expanded to 16 European markets.

2022 From Product to Medical Device

  • Achieved ISO 13485 certification as a medical device manufacturer (TÜV SÜD).

  • CE Mark (Class IIb under EU MDR 745/2017) — PMcardio becomes the world's first CE-certified AI-powered ECG platform for cardiovascular diagnosis under the new EU Medical Device Regulation.

  • Closed €6.2M Seed round. Investors: Venture to Future Fund, CB ESPRI Impact One, BPD partners, and angels.

  • Diagnostic coverage expanded from 23 to 38 conditions.

2021 First Recognition

  • Scientific Advisory Board established with founding members Prof. Dr. Jozef Bartunek, Prof. Dr. Robert Hatala, and Prof. Dr. Leor Perl.

  • R&D partnership established with the Cardiovascular Research Center Aalst, Belgium.

2020 Foundation

  • Powerful Medical founded by Martin Herman, Dr. Robert Herman, Felix Bauer, Viktor Jurasek, Simon Rovder, and Timotej Palus.

  • Raised €1.2M pre-seed from Zero Gravity Capital

Leadership Team

Different minds driven by the same vision

Powerful Medical, backed by 28 leading cardiologists and steered by our prestigious Scientific Board, merges decades of expertise in patient care, clinical research, and medical devices. Our research is effectively translated into market-ready solutions, thanks to our diverse team of over 50 experts, including physicians, data scientists, AI pioneers, software engineers, regulatory specialists, and commercial strategists.

Leadership Team

Martin Herman

Martin Herman

Co-founder and CEO
Dr. Robert Herman, PhD

Dr. Robert Herman, PhD

Co-founder and Chief Medical Officer
Felix Bauer

Felix Bauer

Co-founder and COO
Viktor Jurasek

Viktor Jurasek

Co-founder and CPO
Simon Rovder

Simon Rovder

Co-founder and CTO
Dr. Jozef Bartunek, PhD

Dr. Jozef Bartunek, PhD

Co-Founder and Chair, Clinical Strategy and Advisory Board

Commercial and Partnerships

Michal Martonak

Michal Martonak

Commercial Lead
Amani Farid

Amani Farid

Head of Strategic Partnerships
Daniel Rusin

Daniel Rusin

Europe Sales Director
Mike Wall

Mike Wall

US Commercial

Technology and Regulatory

Adam Rafajdus

Adam Rafajdus

Head of AI
Arezou Azar, PhD

Arezou Azar, PhD

US and Global Regulatory Advisor
Gabriela Rovder Sklencarova

Gabriela Rovder Sklencarova

Head of Infrastructure
Adam Dej

Adam Dej

Head of PMcardio for Organizations Engineering
Arieh Levy

Arieh Levy

Head of PMcardio for Individuals

Clinical

Dr. Pendell Meyers

Dr. Pendell Meyers

ACS Pathway Lead
Dr. Anthony Demolder, PhD

Dr. Anthony Demolder, PhD

HF Pathway Lead
Dr. Timea Kisova

Dr. Timea Kisova

Clinical Research Lead

People

Matus Horvath

Matus Horvath

Head of People

Business Advisory Board

Dr. Dave Pearson

Dr. Dave Pearson

Business Advisor

Acute Coronary Syndrome (ACS) Pathway

Prof. Dr. Timothy D. Henry

Prof. Dr. Timothy D. Henry

ACS Pathway Advisor
Prof. Dr. Jozef Bartunek, PhD

Prof. Dr. Jozef Bartunek, PhD

Co-Founder and Chair, Clinical Strategy and Advisory Board
Prof. Dr. Marco Valgimigli, PhD

Prof. Dr. Marco Valgimigli, PhD

ACS Pathway Advisor
Dr. Scott Sharkey

Dr. Scott Sharkey

ACS Pathway Advisor
Prof. Dr. Emanuele Barbato, PhD

Prof. Dr. Emanuele Barbato, PhD

ACS Pathway Advisor
Prof. Dr. Stephen W. Smith

Prof. Dr. Stephen W. Smith

ACS Pathway Advisor
Dr. Suzanne J. Baron, MSc

Dr. Suzanne J. Baron, MSc

ACS Pathway Advisor
Prof. Dr. Leor Perl

Prof. Dr. Leor Perl

ACS Pathway Advisor

Heart Failure & Arrhythmia

Prof. Dr. Robert Hatala, PhD

Prof. Dr. Robert Hatala, PhD

Co-founder & Chief Scientist, Powerful Medical
Dr. Ward Heggermont, PhD

Dr. Ward Heggermont, PhD

HF and Arrhythmia Pathways Advisor
Dr. Martin Penicka, PhD

Dr. Martin Penicka, PhD

HF and Arrhythmia Pathways Advisor
Dr. Tom De Potter

Dr. Tom De Potter

HF and Arrhythmia Pathways Advisor
Darkened grid of Powerful Medical team member portraits used as a video thumbnail
Powerful Medical heart logo mark in white

And many others

PMcardio wordmark outline on a textured blue media kit background

Media Kit

Logos, brand assets, product visuals, and company
information for press and media use.

Learn more

Two Powerful Medical colleagues reviewing a result on a smartphone in the office

Careers

Join the team building the AI standard
in cardiovascular care.

Learn more

Martin Herman

Co-founder and CEO

Martin started coding at 14 and moved to Silicon Valley at 18, founding several companies including a US-based startup before returning to Europe with his brother Robert to build Powerful Medical. He comes from a family of doctors, which shaped his conviction that AI belongs wherever it can genuinely save lives. Forbes 30 Under 30 (Europe 2024).

Martin Herman

Dr. Robert Herman, PhD

Co-founder and Chief Medical Officer

Robert is a physician-scientist who served on the Research, Digital and Innovation Committee of the European Society of Cardiology. He bridges medicine and AI, connecting clinicians, researchers, regulators, and trial leaders to translate algorithms into clinical practice. He founded multiple AI ECG models, leads international clinical trials validating them, is a recipient of the Journal of the American College of Cardiology Spencer King Award, and was named to Forbes 30 Under 30 Europe 2024.

Dr. Robert Herman, PhD

Felix Bauer

Co-founder and COO

Felix was part of the Hyperloop team that repeatedly competed and won in Elon Musk’s SpaceX Hyperloop Pod Competition. He holds a degree from the Technical University of Munich and brings a rare combination of engineering rigor, regulatory discipline, and operational excellence to the company, spearheading operations, compliance, regulatory, quality management, and global market access since day one.

Felix Bauer

Viktor Jurasek

Co-founder and CPO

Viktor was modding computer games before his teens and has spent the last decade shipping digital products across advertising, finance, and healthcare. As co-founder and CPO, he has led PMcardio's product and design since the first prototype, setting the bar for how a clinical-grade tool should feel in a physician's hands — fast, clear, and trustworthy at the point of care.

Viktor Jurasek

Simon Rovder

Co-founder and CTO

Simon began his engineering career at Microsoft and holds a Master's degree in Informatics from the University of Edinburgh. He built and scaled Powerful Medical's technology organization from the ground up to a team of 20+ engineers, leading the architecture of a CE-certified Class IIb medical device now deployed in hospitals across Europe.

Simon Rovder

Dr. Jozef Bartunek, PhD

Co-Founder and Chair, Clinical Strategy and Advisory Board

Interventional cardiologist and Co-director of the Cardiovascular Center in Aalst, Belgium — one of the world's leading heart centers. A Fogarty International NIH Fellow at Harvard Medical School and visiting Professor of Medicine at Catholic University Leuven, he has authored more than 240 peer-reviewed publications in heart failure and structural heart disease, and anchors Powerful Medical's clinical and research strategy.

Dr. Jozef Bartunek, PhD

Michal Martonak

Commercial Lead

A mathematician by training, Michal leads commercial strategy, go-to-market, and strategic partnerships with healthcare providers and clinical institutions worldwide. He previously built Powerful Medical's data and clinical partnerships function, acquiring the large-scale clinical datasets that underpin the company's certified AI models.

Michal Martonak

Amani Farid

Head of Strategic Partnerships

Amani leads partnership strategy with a hands-on approach to integration, unlocking long-term value through collaboration and scale. A University of Chicago Law School-trained attorney and former M&A and capital markets associate at two top international law firms, she brings the rare combination of legal precision and commercial execution refined across nearly a decade at Stryker and as VP of Corporate Development at RapidAI — spanning medtech, digital health, and AI-driven diagnostics.

Amani Farid

Daniel Rusin

Europe Sales Director

Daniel leads commercial strategy, go-to-market execution, and market expansion across Europe at Powerful Medical, building partnerships with hospitals and healthcare providers that translate AI-powered cardiovascular diagnostics into real clinical adoption and measurable patient outcomes. He brings over twenty years of experience across healthcare, energy, and telecommunications, with a track record of scaling revenue, building high-performing sales teams, and executing complex transformation projects. Before Powerful Medical, he served as Chief Sales Officer at Carebot AI and held senior leadership roles at Medirex Group — one of Central Europe's largest medical laboratory networks — where he led major digital and commercial innovations.

Daniel Rusin

Mike Wall

US Commercial

Mike brings more than twenty years at UnitedHealth Group to the table, where he served health plans, employer groups, and public-sector entities as a consultative healthcare sales executive. He combines market intelligence, clinical insight, and financial acumen — the three ingredients needed to bring AI-powered diagnostics into US health systems at scale.

Mike Wall

Adam Rafajdus

Head of AI

Adam is the Head of AI at Powerful Medical, working across the full lifecycle of bringing AI into clinical practice - from data infrastructure and model development to regulatory clearance. He leads the team behind the Queen of Hearts™ AI ECG models, the company's ECG digitization pipeline, and its broader AI portfolio. Focused on AI since university, Adam joined as an MLOps Engineer and has grown into his current role over six years.

Adam Rafajdus

Arezou Azar, PhD

US and Global Regulatory Advisor

Arezou helps shape and guide the company’s global regulatory strategy across the FDA, EU MDR, and international frameworks. She has been part of nearly every major breakthrough in AI cardiology and is an expert in US and global regulatory strategy, SaMD/digital health launches, with experience at Eko Health, Verily, AliveCor, Cardiologs, and Apple. She specializes in regulatory strategy in high-paced global organizations.

Arezou Azar, PhD

Gabriela Rovder Sklencarova

Head of Infrastructure

Gabriela designs the scalable, secure, distributed systems that keep PMcardio running around the clock for clinicians worldwide. She joined from Google, where she was a senior software engineer building core libraries that kept Google's services resilient against billions of requests, and holds a BA and MA in Computer Science from the University of Cambridge.

Gabriela Rovder Sklencarova

Adam Dej

Head of PMcardio for Organizations Engineering

Adam leads engineering for PMcardio for Organizations at Powerful Medical, driving platform architecture, backend systems, and infrastructure behind one of the company’s key growth products. He began programming at 13, entered professional IT at 17, and studied computer security at Comenius University’s Faculty of Mathematics, Physics and Informatics. Known for technical depth across distributed systems, infrastructure, and security, he builds scalable and resilient software with a sharp focus on customer impact. He also champions responsible use of AI and LLMs as force multipliers for modern engineering teams.

Adam Dej

Arieh Levy

Head of PMcardio for Individuals

Arieh leads the PMcardio for Individuals product at Powerful Medical, guiding its development as a clinical tool for emergency physicians, cardiologists, and primary care physicians. He holds a First Class MEng in Biomedical Engineering from Imperial College London, where he specialised in AI for cardiology, building physics-informed neural networks to model atrial electrical properties, giving him a background that bridges the clinical and technical demands of building a certified AI medical device used at the bedside every day.

Arieh Levy

Dr. Pendell Meyers

ACS Pathway Lead

Emergency medicine physician, prolific educator, and Co-Editor of Dr. Smith's ECG Blog. He is one of the leading voices behind the Occlusion Myocardial Infarction (OMI) paradigm, the clinical framework that reshaped how heart attacks are identified from the ECG — and which sits at the core of the Queen of Hearts™ model.

Dr. Pendell Meyers

Dr. Anthony Demolder, PhD

HF Pathway Lead

Research physician with a PhD on arrhythmias in heritable thoracic aortic disease. He has led international studies at the intersection of cardiology and AI — including earlier work on atrial fibrillation at AZ Sint-Jan Brugge — and now drives Powerful Medical's heart failure pathway and LVsense™ AI model development.

Dr. Anthony Demolder, PhD

Dr. Timea Kisova

Clinical Research Lead

Timea leads Powerful Medical's global external validation studies, including the multi-country AI ECG TIMI Study. With a background in biomedical sciences and a medical degree from Barts and The London School of Medicine and Dentistry, she brings the clinical discipline required to generate the prospective, real-world evidence behind every PMcardio module.

Dr. Timea Kisova

Matus Horvath

Head of People

Matus leads hiring strategy and culture at Powerful Medical, bringing a strong track record of building and scaling high-performing teams. He previously ran the People Team at Slido, the SaaS startup acquired by Cisco, where he played a key role in scaling a fast-growing, values-driven organization. His broader experience now shapes Powerful Medical's growth, culture, and talent strategy.

Matus Horvath

Dr. Dave Pearson

Business Advisor

Academic emergency medicine physician, entrepreneur, investor, and researcher with nearly two decades at Atrium Health, one of US largest health systems. Brings expertise at the intersection of clinical care, healthcare innovation, and strategic leadership.

Dr. Dave Pearson

Prof. Dr. Timothy D. Henry

ACS Pathway Advisor

Leading expert in interventional cardiology and STEMI treatment. Co-founder and principal investigator of the Midwest STEMI Consortium, a registry of more than 20,000 consecutive STEMI activations. Presenting author for the TCT 2025 Late-Breaking Clinical Science on Queen of Hearts.

Prof. Dr. Timothy D. Henry

Prof. Dr. Jozef Bartunek, PhD

Co-Founder and Chair, Clinical Strategy and Advisory Board

Interventional cardiologist and Co-director of the Cardiovascular Center in Aalst, Belgium — one of the world's leading heart centers. A Fogarty International NIH Fellow at Harvard Medical School and visiting Professor of Medicine at Catholic University Leuven, he has authored more than 240 peer-reviewed publications in heart failure and structural heart disease, and anchors Powerful Medical's clinical and research strategy.

Prof. Dr. Jozef Bartunek, PhD

Prof. Dr. Marco Valgimigli, PhD

ACS Pathway Advisor

Head of Cardiology at Cardiocentro Ticino and Principal Investigator of the TITAN-OMI randomized controlled trial. His research has shaped both European and US clinical practice guidelines on coronary stents, antithrombotic therapy, and vascular access.

Prof. Dr. Marco Valgimigli, PhD

Dr. Scott Sharkey

ACS Pathway Advisor

Chief Medical Officer of the Minneapolis Heart Institute Foundation and practicing cardiologist at Allina Health Minneapolis Heart Institute. Co-founder of the STEMI Midwest consortium and Takotsubo cardiomyopathy research program and a widely published clinical investigator in STEMI care.

Dr. Scott Sharkey

Prof. Dr. Emanuele Barbato, PhD

ACS Pathway Advisor

Interventional cardiologist specializing in coronary artery disease and coronary physiology. Acting president of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and contributor to the clinical practice guidelines for STEMI care.

Prof. Dr. Emanuele Barbato, PhD

Prof. Dr. Stephen W. Smith

ACS Pathway Advisor

Faculty physician in Emergency Medicine at Hennepin County Medical Center and Professor of Emergency Medicine at the University of Minnesota. Co-inventor of the OMI paradigm and editor of Dr. Smith's ECG Blog, the most-visited US-based ECG interpretation blog.

Prof. Dr. Stephen W. Smith

Dr. Suzanne J. Baron, MSc

ACS Pathway Advisor

Director of Interventional Cardiology Research at Massachusetts General Hospital. Holds a Master's degree in health economics from Harvard School of Public Health. Expert in cardiovascular device impact on healthcare costs and patient-reported outcomes.

Dr. Suzanne J. Baron, MSc

Prof. Dr. Leor Perl

ACS Pathway Advisor

Director of Complex Cardiac Interventions and Chief Innovation Officer at Rabin Medical Center. Graduate of the Stanford Biodesign Program.

Prof. Dr. Leor Perl

Prof. Dr. Robert Hatala, PhD

Co-founder & Chief Scientist, Powerful Medical

Head of the Arrhythmia and Pacing department at the National Institute of Cardiovascular Diseases in Slovakia. More than 150 publications and 10,000 citations. Contributor to ESC clinical practice guidelines and executive editor of the European Heart Journal since 2020.

Prof. Dr. Robert Hatala, PhD

Dr. Ward Heggermont, PhD

HF and Arrhythmia Pathways Advisor

Co-director at the Cardiovascular Center of Aalst Hospital, specializing in heart failure. Research focus at the intersection of cardiology, virology, and metabolism.

Dr. Ward Heggermont, PhD

Dr. Martin Penicka, PhD

HF and Arrhythmia Pathways Advisor

Cardiologist at the Cardiac Center Aalst since 2009, specializing in non-invasive imaging and valvular disease. Fellow of the European Society of Cardiology (FESC) and the European Association of Cardiovascular Imaging (FEACVI).

Dr. Martin Penicka, PhD

Dr. Tom De Potter

HF and Arrhythmia Pathways Advisor

Cardiologist specializing in Pacemaker Device Therapy and Electrophysiology. Leads the electrophysiology unit at the Heart Center in Aalst, holds an executive board position at the European Heart Academy, and serves as EHRA scientific program committee co-chair.

Dr. Tom De Potter